CN102083841A - 用于治疗神经变性疾病的新型螺哌啶类化合物 - Google Patents
用于治疗神经变性疾病的新型螺哌啶类化合物 Download PDFInfo
- Publication number
- CN102083841A CN102083841A CN2009801261947A CN200980126194A CN102083841A CN 102083841 A CN102083841 A CN 102083841A CN 2009801261947 A CN2009801261947 A CN 2009801261947A CN 200980126194 A CN200980126194 A CN 200980126194A CN 102083841 A CN102083841 A CN 102083841A
- Authority
- CN
- China
- Prior art keywords
- methyl
- thia
- fluorophenyl
- alkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CC1C*CC1 Chemical compound CC1C*CC1 0.000 description 4
- MTYDOWZLPPHCPC-BJQOMGFOSA-N C[C@@H](CC(CN)(CC1)Nc2cc(F)ccc2)N1C(OCc1ccccc1)=O Chemical compound C[C@@H](CC(CN)(CC1)Nc2cc(F)ccc2)N1C(OCc1ccccc1)=O MTYDOWZLPPHCPC-BJQOMGFOSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5042308P | 2008-05-05 | 2008-05-05 | |
| US61/050,423 | 2008-05-05 | ||
| PCT/IB2009/051815 WO2009136350A1 (en) | 2008-05-05 | 2009-05-04 | Novel class of spiro piperidines for the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102083841A true CN102083841A (zh) | 2011-06-01 |
Family
ID=40902870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801261947A Pending CN102083841A (zh) | 2008-05-05 | 2009-05-04 | 用于治疗神经变性疾病的新型螺哌啶类化合物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20110046160A1 (https=) |
| EP (1) | EP2300484B1 (https=) |
| JP (1) | JP2011519913A (https=) |
| KR (1) | KR20110000749A (https=) |
| CN (1) | CN102083841A (https=) |
| AP (1) | AP2010005456A0 (https=) |
| AT (1) | ATE537178T1 (https=) |
| AU (1) | AU2009245322B2 (https=) |
| BR (1) | BRPI0912433A2 (https=) |
| CA (1) | CA2721786A1 (https=) |
| CO (1) | CO6321280A2 (https=) |
| CR (1) | CR11759A (https=) |
| DO (1) | DOP2010000317A (https=) |
| EA (1) | EA201001566A1 (https=) |
| EC (1) | ECSP10010597A (https=) |
| ES (1) | ES2375913T3 (https=) |
| IL (1) | IL208793A0 (https=) |
| MA (1) | MA32290B1 (https=) |
| MX (1) | MX2010012066A (https=) |
| NZ (1) | NZ588589A (https=) |
| SV (1) | SV2010003725A (https=) |
| WO (1) | WO2009136350A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| EP2556076A2 (en) * | 2010-04-09 | 2013-02-13 | Pfizer Inc. | Novel sultam compounds |
| EP2694489B1 (en) | 2011-04-07 | 2017-09-06 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP2694521B1 (en) | 2011-04-07 | 2015-11-25 | Merck Sharp & Dohme Corp. | Pyrrolidine-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| RU2014111055A (ru) | 2011-08-22 | 2015-09-27 | Мерк Шарп И Доум Корп. | 2-спирозамещенные иминотиазины и их моно- и диоксиды в качестве ингибиторов bace, композиции и их применение |
| US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
| WO2016100940A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006044497A2 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| CN1902202A (zh) * | 2004-01-08 | 2007-01-24 | 弗·哈夫曼-拉罗切有限公司 | 二氮杂－螺哌啶衍生物 |
| WO2007011810A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006044497A (ja) * | 2004-08-05 | 2006-02-16 | Toyota Motor Corp | 車輪情報処理装置 |
| AU2007342368A1 (en) * | 2007-01-04 | 2008-07-17 | Merck & Co., Inc. | Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease |
-
2009
- 2009-05-04 US US12/990,739 patent/US20110046160A1/en not_active Abandoned
- 2009-05-04 KR KR1020107024794A patent/KR20110000749A/ko not_active Ceased
- 2009-05-04 WO PCT/IB2009/051815 patent/WO2009136350A1/en not_active Ceased
- 2009-05-04 ES ES09742523T patent/ES2375913T3/es active Active
- 2009-05-04 CA CA2721786A patent/CA2721786A1/en not_active Abandoned
- 2009-05-04 EA EA201001566A patent/EA201001566A1/ru unknown
- 2009-05-04 AT AT09742523T patent/ATE537178T1/de active
- 2009-05-04 EP EP09742523A patent/EP2300484B1/en active Active
- 2009-05-04 AU AU2009245322A patent/AU2009245322B2/en not_active Ceased
- 2009-05-04 JP JP2011508035A patent/JP2011519913A/ja not_active Withdrawn
- 2009-05-04 NZ NZ588589A patent/NZ588589A/en not_active IP Right Cessation
- 2009-05-04 BR BRPI0912433A patent/BRPI0912433A2/pt not_active Application Discontinuation
- 2009-05-04 CN CN2009801261947A patent/CN102083841A/zh active Pending
- 2009-05-04 MX MX2010012066A patent/MX2010012066A/es not_active Application Discontinuation
- 2009-05-04 AP AP2010005456A patent/AP2010005456A0/xx unknown
-
2010
- 2010-10-18 IL IL208793A patent/IL208793A0/en unknown
- 2010-10-21 DO DO2010000317A patent/DOP2010000317A/es unknown
- 2010-10-26 CR CR11759A patent/CR11759A/es not_active Application Discontinuation
- 2010-11-05 SV SV2010003725A patent/SV2010003725A/es not_active Application Discontinuation
- 2010-11-05 MA MA33328A patent/MA32290B1/fr unknown
- 2010-11-09 EC EC2010010597A patent/ECSP10010597A/es unknown
- 2010-11-11 CO CO10141834A patent/CO6321280A2/es not_active Application Discontinuation
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1902202A (zh) * | 2004-01-08 | 2007-01-24 | 弗·哈夫曼-拉罗切有限公司 | 二氮杂－螺哌啶衍生物 |
| WO2006044497A2 (en) * | 2004-10-13 | 2006-04-27 | Merck & Co., Inc. | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease |
| WO2007011810A1 (en) * | 2005-07-18 | 2007-01-25 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2008030412A2 (en) * | 2006-09-07 | 2008-03-13 | Merck & Co., Inc. | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
Non-Patent Citations (2)
| Title |
|---|
| JAMES H. PARK,等: "Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition.", 《J NEUROSCI.》 * |
| 房长进: "《STN检索报告》", 31 October 2012 * |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0912433A2 (pt) | 2015-12-22 |
| EA201001566A1 (ru) | 2011-04-29 |
| CO6321280A2 (es) | 2011-09-20 |
| EP2300484A1 (en) | 2011-03-30 |
| CR11759A (es) | 2010-11-22 |
| ES2375913T3 (es) | 2012-03-07 |
| ATE537178T1 (de) | 2011-12-15 |
| US20110046160A1 (en) | 2011-02-24 |
| JP2011519913A (ja) | 2011-07-14 |
| MA32290B1 (fr) | 2011-05-02 |
| SV2010003725A (es) | 2011-07-05 |
| KR20110000749A (ko) | 2011-01-05 |
| DOP2010000317A (es) | 2010-11-15 |
| AU2009245322A1 (en) | 2009-11-12 |
| AP2010005456A0 (en) | 2010-12-31 |
| WO2009136350A1 (en) | 2009-11-12 |
| CA2721786A1 (en) | 2009-11-12 |
| IL208793A0 (en) | 2010-12-30 |
| NZ588589A (en) | 2012-07-27 |
| ECSP10010597A (es) | 2010-12-30 |
| MX2010012066A (es) | 2010-12-06 |
| AU2009245322B2 (en) | 2011-07-14 |
| EP2300484B1 (en) | 2011-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4932065B2 (ja) | βセクレターゼ阻害剤としてのラクタム | |
| CN102686580B (zh) | 用作酪蛋白激酶抑制剂的咪唑衍生物 | |
| US8933095B2 (en) | KAT II inhibitors | |
| IL275058B1 (en) | Sulphonyl urea derivatives as nlrp3 inflammasome modulators | |
| US7700591B2 (en) | Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors | |
| CN102083841A (zh) | 用于治疗神经变性疾病的新型螺哌啶类化合物 | |
| JP2012519682A (ja) | ガンマ−セクレターゼモジュレーターとしての新規フェニルイミダゾールおよびフェニルトリアゾール | |
| JP2023551110A (ja) | Ｉｌ‐１７モジュレーターとしてのジシクロプロピルメチル誘導体 | |
| JP2004512323A (ja) | Ｃｃｒ５ケモカイン受容体活性のピロリジンモジュレーター | |
| TW202309006A (zh) | 作為ｓｉｇｍａ配體的新穎吡啶磺醯胺衍生物、其製備方法及用途，以及包含該吡啶－磺醯胺衍生物的醫藥組成物 | |
| CN101563323B (zh) | 螺-哌啶衍生物 | |
| JP2013523806A (ja) | スルタム化合物 | |
| HK1153457A (zh) | 用於治疗神经变性疾病的新型螺哌啶类化合物 | |
| JP2013518094A (ja) | γ−セクレターゼモジュレーターとしてのアミノシクロヘキサンおよびアミノテトラヒドロピランならびに関連化合物 | |
| HK1163066A (en) | Lactams as beta secretase inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1153457 Country of ref document: HK |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110601 |
|
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1153457 Country of ref document: HK |